|

Empagliflozin + Carvedilol Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • Post Graduate Institute of Medical Education and Research, Chandigarh1

Indications

  • Empagliflozin1
  • Cirrhotic Cardiomyopathy1
  • Cardiometabolic Risk Factors1
  • Heart Disease1
  • Cirrhosis1

Other1 trial

DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.